Bausch Health Secures $600 Million Financing Facility in Collaboration with KKR
Saturday, July 08, 2023
Bausch Health Companies Inc. and KKR have announced a significant financing agreement. Bausch Receivables Funding LP, a wholly-owned subsidiary of Bausch Health, has secured a non-recourse financing facility of $600 million with KKR and its credit funds and accounts. The facility is backed by specific accounts receivables originated by another subsidiary of Bausch Health.
The purpose of the financing facility is to provide Bausch Health with additional liquidity for general corporate purposes. This infusion of funds will support the company's various operational needs and strategic initiatives. The facility has a term of approximately five years, providing a sustained period of financial support.
Houlihan Lokey, Inc. acted as the financial advisor for Bausch Health in this transaction. They provided valuable guidance throughout the process. Finacity Corporation has been appointed as the program administrator, responsible for ongoing program administration, reporting, and providing analytic and execution support.
This financing facility signifies a significant milestone for Bausch Health, enhancing its financial strength and stability. The access to $600 million in funding enables the company to navigate market dynamics, invest in research and development, pursue strategic acquisitions, and expand its healthcare product and service portfolio. The collaboration with KKR demonstrates confidence in Bausch Health's long-term growth prospects.
With this financing agreement, Bausch Health reaffirms its commitment to stakeholders and its ability to deliver innovative healthcare solutions while maintaining a solid financial foundation. The partnership with KKR and the increased liquidity position the company for continued success and sustainable growth in the dynamic healthcare industry.